BRIEF-Basilea Pharmaceutica says isavuconazole receives orphan drug designations in Europe for treatment of invasive mold infections

July 14 Mon Jul 14, 2014 1:20am EDT

Related Topics

July 14 (Reuters) - Basilea Pharmaceutica AG : * Says isavuconazole receives orphan drug designations in Europe for treatment of invasive mold infections * Source text for Eikon [ID:nHUG6y9z1k ] * Further company coverage

FILED UNDER: